Axcelis Technologies (NASDAQ:ACLS) Shares Up 5.3% Following … – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Rating) traded up 5.3% during trading on Thursday after Needham & Company LLC raised their price target on the stock from $77.00 to $100.00. Needham & Company LLC currently has a buy rating on the stock. Axcelis Technologies traded as high as $83.23 and last traded at $82.86. 3,224 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 346,857 shares. The stock had previously closed at $78.69.
Other analysts also recently issued research reports about the stock. StockNews.com downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, December 28th. DA Davidson restated a “buy” rating on shares of Axcelis Technologies in a research note on Tuesday.
Insiders Place Their Bets
In other news, EVP Russell Low sold 7,700 shares of the firm’s stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $73.64, for a total value of $567,028.00. Following the sale, the executive vice president now directly owns 69,293 shares in the company, valued at approximately $5,102,736.52. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, EVP Russell Low sold 7,700 shares of the stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $73.64, for a total value of $567,028.00. Following the completion of the transaction, the executive vice president now owns 69,293 shares of the company’s stock, valued at approximately $5,102,736.52. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Joseph P. Keithley sold 2,000 shares of the business’s stock in a transaction on Thursday, November 10th. The stock was sold at an average price of $74.02, for a total transaction of $148,040.00. Following the sale, the director now directly owns 21,375 shares in the company, valued at approximately $1,582,177.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,510 shares of company stock valued at $2,610,973. 2.15% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Axcelis Technologies
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Edmond DE Rothschild Holding S.A. grew its holdings in shares of Axcelis Technologies by 4.8% during the second quarter. Edmond DE Rothschild Holding S.A. now owns 3,134 shares of the semiconductor company’s stock worth $172,000 after purchasing an additional 143 shares during the last quarter. Amalgamated Bank boosted its position in Axcelis Technologies by 0.9% during the 3rd quarter. Amalgamated Bank now owns 15,994 shares of the semiconductor company’s stock worth $969,000 after buying an additional 144 shares during the period. Public Employees Retirement System of Ohio grew its holdings in Axcelis Technologies by 42.8% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 527 shares of the semiconductor company’s stock worth $32,000 after acquiring an additional 158 shares during the last quarter. CWM LLC increased its position in Axcelis Technologies by 36.6% in the 2nd quarter. CWM LLC now owns 702 shares of the semiconductor company’s stock valued at $38,000 after acquiring an additional 188 shares during the period. Finally, Great West Life Assurance Co. Can raised its stake in shares of Axcelis Technologies by 0.7% during the first quarter. Great West Life Assurance Co. Can now owns 28,925 shares of the semiconductor company’s stock valued at $2,243,000 after acquiring an additional 209 shares during the last quarter. Institutional investors and hedge funds own 86.47% of the company’s stock.
Axcelis Technologies Trading Up 4.8 %
The company has a debt-to-equity ratio of 0.07, a current ratio of 3.73 and a quick ratio of 2.64. The company has a market cap of $2.71 billion, a price-to-earnings ratio of 16.39 and a beta of 1.62. The business’s fifty day moving average price is $75.95 and its 200 day moving average price is $66.96.
Axcelis Technologies (NASDAQ:ACLS – Get Rating) last announced its earnings results on Wednesday, November 2nd. The semiconductor company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.13 by $0.08. The firm had revenue of $229.20 million for the quarter, compared to the consensus estimate of $224.38 million. Axcelis Technologies had a return on equity of 28.15% and a net margin of 18.83%. The business’s quarterly revenue was up 29.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.81 EPS. Research analysts anticipate that Axcelis Technologies, Inc. will post 4.79 earnings per share for the current fiscal year.
Axcelis Technologies Company Profile
(Get Rating)
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements.
Recommended Stories
- Get a free copy of the StockNews.com research report on Axcelis Technologies (ACLS)
- Will Trade Desk Inc Bounce Off Its Support Line?
- Conagra Brands: Another Reason To Go Long Consumer Staples In 2023
- Tesla’s Road to Recovery is a Long, Promising One
- GameStop Stock Worth Considering for Another Run in 2023?
- Keep These 3 Dividend Contenders on the 2023 Watch List
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axcelis Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axcelis Technologies wasn’t on the list.
While Axcelis Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
MarketBeat’s analysts have just released their top five short plays for January 2023. Learn which stocks have the most short interest and how to trade them. Enter your email address below to see which companies made the list.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.
© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.